Hand, Foot, and Mouth Disease Symptoms and Clinical Presentation

What Is Hand, Foot, and Mouth Disease

Hand, foot, and mouth disease (HFMD) is a common viral illness caused primarily by enteroviruses, most frequently coxsackievirus A16 and enterovirus 71. The condition spreads through direct contact with nasal secretions, saliva, fluid from blisters, or stool of an infected person. It can also transmit via contaminated surfaces and respiratory droplets. Outbreaks occur most often in late summer and early autumn in temperate climates, though cases appear year-round in tropical regions.

The illness predominantly affects children under five years old, particularly those in daycare or preschool settings where close contact facilitates transmission. Adults can contract the virus but often experience milder or asymptomatic infections. Immunity develops against the specific viral strain that caused infection, though reinfection with a different enterovirus strain remains possible.

HFMD is generally self-limiting, with most cases resolving within seven to ten days without specific medical treatment. The clinical presentation follows a recognizable pattern, though individual experiences vary in severity and symptom combination. Understanding the typical course helps caregivers recognize the illness and monitor for complications that warrant professional evaluation.

Initial Symptoms and Incubation Period

The incubation period—the time between exposure and symptom onset—typically ranges from three to six days. During this window, the infected person may already shed virus and transmit it to others. The first signs often resemble a mild viral syndrome: low-grade fever (usually 38–39°C or 100–102°F), reduced appetite, sore throat, and general malaise. Young children may become irritable or refuse food due to throat discomfort before any visible lesions appear.

Fever frequently precedes the rash by one to two days. Some children experience headache, abdominal discomfort, or mild respiratory symptoms such as runny nose or cough during this prodromal phase. These early symptoms are nonspecific and can mimic other common childhood viral infections, making diagnosis challenging until the characteristic rash develops.

Not every infected individual develops all symptoms. Asymptomatic infections occur, particularly in adults and older children with prior enterovirus exposure. When symptoms do appear, their intensity varies widely—some children remain playful despite fever, while others become notably lethargic. This variability contributes to underreporting and continued community spread.

Characteristic Rash and Oral Lesions

The hallmark of HFMD is the development of vesicular lesions on the hands, feet, and in the mouth. Oral lesions typically appear first as small red macules on the tongue, gums, and inner cheeks that progress to painful ulcers 2–3 mm in diameter with a yellow-gray base and red halo. These ulcers make swallowing painful, leading to drooling, food refusal, and dehydration risk, especially in infants and toddlers.

The cutaneous rash emerges as flat or slightly raised red spots that evolve into small, oval, gray-white vesicles with a surrounding erythematous rim. On the hands and feet, lesions concentrate on the palms, soles, and sides of fingers and toes. Unlike chickenpox vesicles, HFMD lesions are typically non-itchy, though some children report mild tenderness. The rash may also appear on the buttocks, knees, elbows, and genital area.

Lesion count varies from a few scattered spots to dozens. Skin lesions usually heal within five to seven days without scarring, though temporary skin peeling may occur as they resolve. Oral ulcers often persist longer, sometimes remaining painful for up to ten days. The distribution pattern—palms, soles, and oral mucosa—helps distinguish HFMD from other vesicular exanthems.

Symptom Variation by Age Group

Infants and young children under three typically exhibit the classic full presentation: fever, prominent oral ulcers, and extensive cutaneous rash. They face the highest dehydration risk due to inability to communicate thirst and refusal of fluids because of mouth pain. Irritability, sleep disruption, and decreased urine output are common caregiver concerns in this age group.

Older children (ages 4–10) often have milder disease. Fever may be lower or absent, oral lesions fewer and less painful, and the rash sparser. Some present with only oral ulcers (herpangina-like presentation) or only skin lesions. Adolescents and adults frequently experience asymptomatic infection or very mild symptoms—perhaps a brief sore throat or a few hand lesions—leading to unrecognized transmission to susceptible younger contacts.

Immunocompromised individuals of any age may develop more severe, prolonged, or atypical manifestations. Lesions can be more numerous, confluent, or hemorrhagic. Healing may be delayed, and secondary bacterial infection risk increases. These patients require closer monitoring and earlier medical consultation.

• Infants and toddlers: High fever, extensive oral ulcers, widespread rash, high dehydration risk
• Preschool children (3–5 years): Classic presentation, moderate discomfort, typical 7–10 day course
• School-age children (6–12 years): Milder fever, fewer lesions, often shorter duration
• Adolescents and adults: Frequently asymptomatic or very mild, unrecognized carriers
• Immunocompromised patients: Severe, prolonged, or atypical lesions; higher complication risk

Complications and Atypical Presentations

While most HFMD cases resolve without sequelae, complications can occur. Dehydration is the most common, resulting from painful oral lesions that limit fluid intake. Signs include dry mouth, decreased tears, sunken fontanelle in infants, reduced urine output (fewer than three wet diapers in 24 hours), and lethargy. Severe dehydration requires intravenous fluid replacement.

Neurological complications, though rare, are most associated with enterovirus 71 infection. These include aseptic meningitis, encephalitis, acute flaccid paralysis, and brainstem encephalitis. Warning signs include persistent high fever, severe headache, neck stiffness, photophobia, vomiting, altered consciousness, limb weakness, or tremors. Enterovirus 71 outbreaks in the Asia-Pacific region have shown higher rates of neurological involvement compared to coxsackievirus A16.

Atypical presentations have been increasingly recognized, particularly during coxsackievirus A6 outbreaks. These include more widespread vesiculobullous lesions, involvement of unusual sites (face, trunk, perianal area), larger bullae, and subsequent onychomadesis (nail shedding) occurring weeks after acute illness. Eczema coxsackium—a flare of atopic dermatitis with viral lesions superimposed—can occur in children with pre-existing eczema. These variants may mimic other conditions, including herpes simplex, varicella, or Stevens-Johnson syndrome.

When to Consult a Healthcare Professional

Most children with HFMD can be managed at home with supportive care: hydration, pain relief for oral discomfort, and rest. However, certain signs indicate the need for medical evaluation. Seek prompt care if the child shows signs of dehydration (no urine for 6–8 hours, dry mouth, no tears when crying, sunken eyes), appears unusually lethargic or difficult to awaken, has persistent high fever above 39.5°C (103°F) or fever lasting more than three days, or exhibits neurological symptoms such as severe headache, neck stiffness, confusion, or weakness.

Infants under three months with any fever should be evaluated immediately. Children with underlying immune deficiencies, chronic medical conditions, or those taking immunosuppressive medications should have a lower threshold for medical assessment. Pregnant women exposed to HFMD should inform their obstetrician, as enterovirus infection near delivery can rarely transmit to the newborn, potentially causing severe neonatal disease.

Diagnosis is primarily clinical, based on the characteristic symptom constellation. Laboratory testing (viral PCR from throat swab, vesicle fluid, or stool) is reserved for severe cases, outbreak investigations, or when the presentation is atypical. No specific antiviral treatment exists for routine HFMD; management focuses on symptom relief and complication prevention. A healthcare professional can confirm the diagnosis, assess hydration status, rule out secondary bacterial infection, and provide guidance on return-to-school criteria.